Exciting times for Cardiol TherapeuticsSuper excited about what could happen here corporately. So much potential and the fact that this company can possibly offset the mortality rate and assist those who have become sick but continue to suffer physically months and possibly years after. Cardiol could become the talk of the town around the world - time will tell. Yes, lots of water to go under the bridge by then BUT this management team is doing things properly, slowly and methodically. Between the huge potential of selling product through shoppers drug stores, and offering to the world a proactive measure to deal with myocarditis, we could have a multi bagger here. The company only has about 38 million shares out with about 17 million in the bank - or thereabouts. Blue sky from my armchair. Do your own homework before you invest.